- There are no upcoming events available at this time.
. A research collaboration including Ananth Karumanchi, MD, a vascular biologist at BIDMC, and scientists from the University of Massachusetts Medical School and Western Sydney University, showed that an innovative type of therapy using small interfering RNAs can temper the symptoms of preeclampsia in an animal model. The findings suggest that RNA interference therapy could be a potential strategy for the treatment of preeclampsia in humans.
. Ted Kaptchuk, Director of Harvard Medical School’s Program in Placebo Studies and the Therapeutic Encounter at BIDMC, and colleagues have begun to elucidate an ensemble of biochemical processes that may account for how placebos work and why they are more effective for some people, and some disorders, than others. The molecules’ emergence may reveal fundamental flaws in the way we understand the body’s healing mechanisms, and the way we evaluate whether more standard medical interventions in those processes work, or don’t.
. OpenNotes announced that more than 30 million Americans now have access to notes written by their clinicians in fully transparent medical records. OpenNotes is a call to action committed to improving health care by offering patients the opportunity to read notes written by their care team. Previously hidden from patients, these notes can be an essential tool for increasing communication, patient safety and the quality of care.
. Jihye Jang, a PhD Candidate at the Cardiac Magnetic Resonance Center at BIDMC, and colleagues assessed augmented reality’s potential to help cardiologists visualize myocardial scarring in the heart as they perform ventricular tachycardia ablation or other electrophysiological interventions. The team’s findings, published in PLOS ONE, demonstrate that the new technology confers a number of advantages.